Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog

BACKGROUND: Although the new isoxazoline drug fluralaner (Bravecto®) is generally well tolerated in dogs, adverse drug reactions involving neurological dysfunction occurred in individual dogs. However, most of these cases are documented inadequately and none of them is reported and discussed in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaens, Daniela, Rummel, Christoph, Schmidt, Martin, Hamann, Melanie, Geyer, Joachim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686215/
https://www.ncbi.nlm.nih.gov/pubmed/31391054
http://dx.doi.org/10.1186/s12917-019-2016-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686215/
https://www.ncbi.nlm.nih.gov/pubmed/31391054
http://dx.doi.org/10.1186/s12917-019-2016-4

Ejemplares similares